Compare Stocks: OPRX, MDRX, WEAV, and SOPH

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MDRX Veradigm	$5.00	$4.90	$3.25 ▼ $6.00	$611.50M	0.51	116,113 shs	39,702 shs
OPRX OptimizeRx	$8.50 -4.0%	$7.95	$4.54 ▼ $22.25	$166.70M	1.26	190,247 shs	101,177 shs
SOPH SOPHiA GENETICS	$6.73 -7.7%	$7.96	$3.75 ▼ $8.98	$611.60M	0.95	625,793 shs	915,442 shs
WEAV Weave Communications	$7.40 +0.1%	$7.09	$4.24 ▼ $7.70	$591.19M	1.68	1.55 million shs	2.52 million shs

7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MDRX Veradigm	0.00%	+5.26%	+2.04%	+5.26%	+5.93%
OPRX OptimizeRx	+6.76%	+5.61%	+17.06%	+32.29%	-56.60%
SOPH SOPHiA GENETICS	+3.26%	-0.14%	-8.42%	+24.19%	+69.93%
WEAV Weave Communications	0.00%	+0.14%	+0.82%	+2.49%	+11.86%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MDRX Veradigm	$5.00	$4.90	$3.25 ▼ $6.00	$611.50M	0.51	116,113 shs	39,702 shs
OPRX OptimizeRx	$8.50 -4.0%	$7.95	$4.54 ▼ $22.25	$166.70M	1.26	190,247 shs	101,177 shs
SOPH SOPHiA GENETICS	$6.73 -7.7%	$7.96	$3.75 ▼ $8.98	$611.60M	0.95	625,793 shs	915,442 shs
WEAV Weave Communications	$7.40 +0.1%	$7.09	$4.24 ▼ $7.70	$591.19M	1.68	1.55 million shs	2.52 million shs

7 Stocks That Could Lead the Next Market Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MDRX Veradigm	0.00%	+5.26%	+2.04%	+5.26%	+5.93%
OPRX OptimizeRx	+6.76%	+5.61%	+17.06%	+32.29%	-56.60%
SOPH SOPHiA GENETICS	+3.26%	-0.14%	-8.42%	+24.19%	+69.93%
WEAV Weave Communications	0.00%	+0.14%	+0.82%	+2.49%	+11.86%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MDRX Veradigm	0.00	N/A	N/A	N/A
OPRX OptimizeRx	2.56	Moderate Buy	$11.57	36.13% Upside
SOPH SOPHiA GENETICS	2.40	Hold	$10.00	48.59% Upside
WEAV Weave Communications	2.13	Hold	$7.84	6.02% Upside

Current Analyst Ratings Breakdown

Latest OPRX, MDRX, WEAV, and SOPH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/15/2026	SOPH SOPHiA GENETICS	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
10/12/2026	SOPH SOPHiA GENETICS	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$14.00
10/2/2026	WEAV Weave Communications	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)
9/29/2026	OPRX OptimizeRx	B. Riley Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$10.00 ➝ $11.00
8/25/2026	OPRX OptimizeRx	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (D) ➝ Sell (D+)
8/24/2026	WEAV Weave Communications	Raymond James Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Outperform ➝ Market Perform
8/19/2026	WEAV Weave Communications	B. Riley Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Buy ➝ Hold	$8.25 ➝ $7.40
8/19/2026	WEAV Weave Communications	Loop Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Buy ➝ Hold	$7.40
8/18/2026	WEAV Weave Communications	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Accumulate
8/18/2026	WEAV Weave Communications	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Overweight ➝ Hold	$8.00 ➝ $7.40
8/18/2026	WEAV Weave Communications	B. Riley Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy	$8.25

(Data available from 10/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MDRX Veradigm	$1.53B	0.40	N/A	N/A	N/A	∞
OPRX OptimizeRx	$109.43M	1.46	$0.95 per share	8.99	$6.88 per share	1.24
SOPH SOPHiA GENETICS	$77.27M	7.31	N/A	N/A	$0.69 per share	9.75
WEAV Weave Communications	$239.02M	2.48	$0.06 per share	116.72	$1.06 per share	6.98

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MDRX Veradigm	N/A	N/A	23.25	N/A	N/A	N/A	N/A	N/A	N/A
OPRX OptimizeRx	$5.13M	$0.23	36.96	12.88	N/A	4.66%	9.44%	7.11%	11/5/2026 (Estimated)
SOPH SOPHiA GENETICS	-$79M	-$1.15	N/A	N/A	N/A	-93.86%	-132.47%	-45.97%	11/3/2026 (Estimated)
WEAV Weave Communications	-$28.05M	-$0.25	N/A	N/A	N/A	-7.97%	-21.14%	-8.41%	11/4/2026 (Estimated)

Latest OPRX, MDRX, WEAV, and SOPH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/5/2026	Q3 2026	OPRX OptimizeRx	$0.18	N/A	N/A	N/A	$21.19 million	N/A
11/4/2026	Q3 2026	WEAV Weave Communications	$0.04	N/A	N/A	N/A	$69.18 million	N/A
11/3/2026	Q3 2026	SOPH SOPHiA GENETICS	-$0.1980	N/A	N/A	N/A	$24.03 million	N/A
8/12/2026	Q2 2026	OPRX OptimizeRx	$0.1111	$0.16	+$0.0489	-$0.04	$20.20 million	$20.50 million
8/6/2026	Q2 2026	WEAV Weave Communications	$0.0350	$0.04	+$0.0050	-$0.05	$67.88 million	$67.54 million
8/5/2026	Q2 2026	SOPH SOPHiA GENETICS	-$0.21	-$0.26	-$0.05	-$0.30	$21.72 million	$23.31 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
MDRX Veradigm	N/A	N/A	N/A	N/A	N/A
OPRX OptimizeRx	N/A	N/A	N/A	N/A	N/A
SOPH SOPHiA GENETICS	N/A	N/A	N/A	N/A	N/A
WEAV Weave Communications	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MDRX Veradigm	N/A	N/A	N/A
OPRX OptimizeRx	0.14	5.58	5.58
SOPH SOPHiA GENETICS	0.58	2.69	2.55
WEAV Weave Communications	0.09	1.25	1.25

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
MDRX Veradigm	N/A
OPRX OptimizeRx	76.47%
SOPH SOPHiA GENETICS	31.59%
WEAV Weave Communications	86.83%

Insider Ownership

Company	Insider Ownership
MDRX Veradigm	2.29%
OPRX OptimizeRx	7.50%
SOPH SOPHiA GENETICS	4.88%
WEAV Weave Communications	16.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
MDRX Veradigm	2,300	122.30 million	105.18 million	No Data
OPRX OptimizeRx	105	18.84 million	17.42 million	Optionable
SOPH SOPHiA GENETICS	415	83.89 million	79.80 million	Not Optionable
WEAV Weave Communications	904	80.00 million	66.88 million	Optionable

OPRX, MDRX, WEAV, and SOPH Headlines

Recent News About These Companies

Weave Earns 2026 Great Place To Work Certification™

October 15 at 12:51 PM | marketscreener.comM

Weave Communications faces shareholder challenges to merger deal

October 13 at 4:50 PM | tipranks.com

Weave and CareCredit Go Live with Integration That Places Patient Financing Inside the Front-Office Workflow

October 12, 2026 | marketscreener.comM

Head-To-Head Survey: American Well (NYSE:AMWL) and Weave Communications (NYSE:WEAV)

October 8, 2026 | americanbankingnews.com

Weave Communications, Inc. (NYSE:WEAV) Receives Average Rating of "Hold" from Brokerages

October 4, 2026 | marketbeat.com

Bank of America Corp DE Makes New $3 Million Investment in Weave Communications, Inc. $WEAV

September 30, 2026 | marketbeat.com

Healthcare & Life Sciences Private Equity Deal Tracker: Francisco Partners to Acquire Weave Communications

September 25, 2026 | jdsupra.com

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Centerspace (NYSE – CSR), Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Personalis, Inc. (Nasdaq – PSNL)

September 23, 2026 | globenewswire.com

Weave Communications Clears Key Antitrust Hurdle in Acquisition

September 21, 2026 | tipranks.com

WEAV Stock Alert: Halper Sadeh LLC is Investigating Whether Weave Communications, Inc. is Obtaining a Fair Price for its Shareholders

September 19, 2026 | businesswire.com

Weave Ranks No. 1 in G2's Fall 2026 Patient Relationship Management Grid Report

September 18, 2026 | marketscreener.comM

WEAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Weave Communications to Francisco Partners

September 15, 2026 | globenewswire.com

September 9, 2026 | globenewswire.com

Weave Communications, Inc. (WEAV)

August 24, 2026 | finance.yahoo.com

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Iridium Communications Inc. (Nasdaq – IRDM), Bio-Techne Corporation (Nasdaq – TECH)

August 24, 2026 | globenewswire.com

$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - WEAV, BRBS, TDAC and UHG

August 23, 2026 | gurufocus.com

Weave Communications Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Weave Communications, Inc. - WEAV

August 21, 2026 | businesswire.com

Weave Communications to be acquired by Francisco Partners for $650M

August 20, 2026 | mobihealthnews.comM

Weave Communications to be acquired by Francisco Partners

August 20, 2026 | theglobeandmail.com

Weave scooped up for $650M

August 20, 2026 | finance.yahoo.com

Halper Sadeh LLC is Investigating Whether WEAV and FULC are Obtaining Fair Deals for their Shareholders

August 19, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

OPRX, MDRX, WEAV, and SOPH Company Descriptions

Veradigm NASDAQ:MDRX

$5.00 0.00 (0.00%)

As of 03:59 PM Eastern

Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

OptimizeRx NASDAQ:OPRX

$8.50 -0.35 (-3.95%)

Closing price 04:00 PM Eastern

Extended Trading

$8.56 +0.06 (+0.69%)

As of 07:30 PM Eastern

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

SOPHiA GENETICS NASDAQ:SOPH

$6.73 -0.56 (-7.68%)

Closing price 04:00 PM Eastern

Extended Trading

$6.77 +0.04 (+0.56%)

As of 07:54 PM Eastern

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

Weave Communications NYSE:WEAV

$7.40 +0.01 (+0.07%)

Closing price 03:59 PM Eastern

Extended Trading

$7.40 +0.01 (+0.07%)

As of 07:30 PM Eastern

Weave Communications, Inc. provides a customer experience and payments software platform in the United States and Canada. Its platform enables small and medium-sized healthcare businesses to maximize the value of their patient interactions and minimize the time and effort spent on manual or mundane tasks. The company's products include Unified Phone Number; Customized Phone System, a smarter phone system to identify whether incoming calls are from new or current patients, provide information at every call, and manages heavy call times; Softphones to make and receive calls from anywhere with an internet connection; Text Messaging to communicate with patients; Missed Call Text to take action in real time upon notification of a missed call; Missed Text Auto-Reply; Team Chat, a group messaging solution that helps practitioners and their staff communicate with each other from their work stations; and Weave Mobile App; It also offers Weave Reviews and Respond Assistant to request, collect, monitor, and respond to reviews; Weave Email Marketing and Email Assistant; Text Connect to interact with their existing and potential patients online directly through their websites; Weave Payments, a payment processing solution; Practice Analytics provides real-time data on patient retention, appointment scheduling, treatment acceptance rates, and revenue generation; and Call Intelligence. In addition, the company provides Digital Forms to collect patient information; Insurance Verification that provides patient insurance plan details; and Scheduling to send automatic scheduling reminders through text message. It serves customers in dental, optometry, veterinary, medical, plastic surgery, physical therapy, medical spa, and other medical specialty industries. The company was formerly known as Recall Solutions, LLC and changed its name to Weave Communications, Inc. in October 2015. Weave Communications, Inc. was founded in 2008 and is headquartered in Lehi, Utah.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest OPRX, MDRX, WEAV, and SOPH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest OPRX, MDRX, WEAV, and SOPH Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

OPRX, MDRX, WEAV, and SOPH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

OPRX, MDRX, WEAV, and SOPH Company Descriptions

Veradigm NASDAQ:MDRX

OptimizeRx NASDAQ:OPRX

SOPHiA GENETICS NASDAQ:SOPH

Weave Communications NYSE:WEAV

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest OPRX, MDRX, WEAV, and SOPH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest OPRX, MDRX, WEAV, and SOPH Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

OPRX, MDRX, WEAV, and SOPH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

OPRX, MDRX, WEAV, and SOPH Company Descriptions

Veradigm NASDAQ:MDRX

OptimizeRx NASDAQ:OPRX

SOPHiA GENETICS NASDAQ:SOPH

Weave Communications NYSE:WEAV

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools